Alcon stock gains support from Berenberg Buy rating and solid Q2 2026 figures
Published on 09/12/2026 at 14:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Alcon Inc. (ISIN CH0432492467) stock closed at USD 66.03 on the New York Stock Exchange on September 11, 2026, essentially flat after a 0.78% decline during the regular session, keeping the shares near the middle of their recent range according to data from Yahoo Finance.
Berenberg reiterates Buy rating on Alcon stock
According to TipRanks on September 11, 2026, Berenberg Bank analyst Sam England maintained a Buy rating on Alcon and set a price target of CHF 85.00.
The same report notes that Alcon shares last Friday closed at USD 66.72, implying upside potential of roughly 27 percent to the CHF 85.00 target when translated into dollar terms using prevailing exchange rates in mid-September 2026, which signals that the analyst still sees room for appreciation from current levels.
Latest quarterly figures frame earnings momentum
As Yahoo Finance reports for Q2 FY26, Alcon delivered revenue of USD 2.82 billion, reflecting the company’s current scale in the global eye-care market.
For the same Q2 FY26 period, normalized GAAP earnings per share came in at USD 0.84 versus an estimate of USD 0.76, meaning Alcon beat the consensus by USD 0.08 per share, a positive surprise of about 10.5 percent that underlines improving profitability.
On a trailing twelve-month basis, Alcon’s revenue stands at USD 10.86 billion and net income attributable to common shareholders at USD 643 million according to Yahoo Finance, giving investors a sense of the company’s earnings power around mid-2026.
Price level, market capitalization and trading range
Per data published by Yahoo Finance, Alcon stock finished at USD 66.03 on September 11, 2026 on the NYSE after a drop of USD 0.52, corresponding to a 0.78% decline versus the previous close.
The same overview shows a 52-week range between USD 69.44 and USD 101.10 as of September 11, 2026, so the latest close leaves Alcon shares about 4.6 percent above the 52-week low and roughly 34.7 percent below the 52-week high, indicating that the stock trades in the lower half of its annual corridor.
According to the market capitalization snapshot on CompaniesMarketCap, Alcon’s market cap was USD 32.04 billion as of September 2026, down 19.14% from the prior year, a sign that valuation has compressed despite the company’s ongoing revenue growth.
Analyst consensus and upcoming earnings date
The analyst overview on Yahoo Finance indicates an average analyst price target of USD 85.24 for Alcon, compared with the USD 66.03 share price on September 11, 2026, which implies potential upside of about 29.1 percent if the consensus scenario materializes.
The same source lists an earnings date of November 10, 2026 as the next scheduled reporting date for Alcon, giving investors a clear timeline for the company’s upcoming quarterly update.
Stock closes steady on the NYSE
In summary, Alcon stock ended trading on the NYSE at USD 66.03 on September 11, 2026, with a modest decline of 0.78% on the day, leaving the company valued at roughly USD 32.04 billion and positioned well below its 52-week high but above the recent low, while analysts such as Berenberg Bank continue to see upside based on the latest Q2 FY26 earnings beat.
Key data on Alcon stock
- Company: Alcon Inc.
- ISIN: CH0432492467
- Ticker: ALC
- Trading venue: NYSE
- Price (as of September 11, 2026, 4:00): 66.03 USD
- Market capitalization: 32.04 billion USD (as of September 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: November 10, 2026
